Efficacy and Safety of DKF-306 in Patients With Periodontal Diseases

Phase 4 Unknown 158 enrolled Dongkook Pharmaceutical Co., Ltd.

RandomizedParallel-groupDouble-blindTreatment

Summary

This is a multi-center, randomized, double-blinded, placebo-controlled study to evaluated the efficacy and safety of DKF-306 in patients with periodontal diseases.

Timeline

Start: 2020-05-22
Primary completion: 2022-06
Completion: 2022-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	DKF-306	Unknown	—	—

Efficacy and Safety of DKF-306 in Patients With Periodontal Diseases

Summary

Timeline

Drugs

Indications